DOI: 10.1055/s-00000161

The Journal of Knee Surgery

References

Eriksson BI, Dahl OE, Rosencher N. , et al; RE-MODEL Study Group.
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.

J Thromb Haemost 2007;
5 (11) 2178-2185

Eriksson BI, Dahl OE, Rosencher N. , et al; RE-MODEL Study Group.
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.

J Thromb Haemost 2007;
5 (11) 2178-2185

Download Bibliographical Data

Search in:
Access: